Carbon Nanotube as a Tool for Fighting Cancer

Abstract

In 2015, cancer was the cause of almost 22% of deaths worldwide. The high frequency of relapsing diseases and metastasis requires the development of new diagnostic and therapeutic approaches, and the use of nanomaterials is a promising tool for fighting cancer. Among the more extensively studied nanomaterials are carbon nanotubes (CNTs), synthesized as graphene sheets, whose spiral shape is varied in length and thickness. Their physicochemical features, such as the resistance to tension, and thermal and electrical conductivity, allow their application in several fields. In this review, we show evidence supporting the applicability of CNTs in biomedical practice as nanocarriers for drugs and immunomodulatory material, emphasizing their potential for use in cancer treatment.

Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

“…Therefore, there is a need to discuss the toxicity behavior of such modified nanoformulation [82]. Generally, most of the mass of P 10 is considered to be harmless in nature, but it is evident that the particle P 10 is responsible for the pro-inflammatory effects [83]. P 10 is also implicated in causing adverse effects, which is supported by the substantial toxicological data [84].…”

Is Nanotechnology Helping in the Fight Against COVID-19?

“…Carbon-based nanomaterials such as carbon nanotubes (CNTs), graphenes, and fullerenes NPs present interesting physicochemical properties for innovative scientific and technological applications (Comparetti et al, 2018). CNTs have covalent bonds (sp 2 +sp 3 hybrid phases) and excellent electric conductivity, enabling their use in different research fields.…”

Molecular engineering of the last-generation CNTs in smart cancer therapy by grafting PEG–PLGA–riboflavin

“…CNTs can encapsulate the drug and deliver them to the target. [18][19][20] The large surface area of carbon nanotubes (CNT) can offer multiattachment sites for the drugs. A drug delivery system with doxorubicin and carbon nanotubes has highlighted the effect of size; the doxorubicin (DOX) molecule can inter CNT, once the diameter is larger than 1.25 nm.…”